Cargando…
Biodegradable hollow mesoporous organosilica nanotheranostics (HMONs) as a versatile platform for multimodal imaging and phototherapeutic-triggered endolysosomal disruption in ovarian cancer
A major impediment in the development of nanoplatform-based ovarian cancer therapy is endo/lysosome entrapment. To solve this dilemma, a hollow mesoporous organosilica-based nanoplatform (HMON@CuS/Gd(2)O(3)) with a mild-temperature photothermal therapeutic effect and multimodal imaging abilities was...
Autores principales: | Li, Pengfei, Lin, Bingquan, Chen, Zhian, Liu, Pan, Liu, Jiaqi, Li, Weili, Liu, Ping, Guo, Zhaoze, Chen, Chunlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725973/ https://www.ncbi.nlm.nih.gov/pubmed/34967262 http://dx.doi.org/10.1080/10717544.2021.2021322 |
Ejemplares similares
-
Biodegradable hollow mesoporous organosilica nanotheranostics (HMON) for multi-mode imaging and mild photo-therapeutic-induced mitochondrial damage on gastric cancer
por: Guo, Weihong, et al.
Publicado: (2020) -
Biodegradable, pH-Sensitive Hollow Mesoporous Organosilica Nanoparticle (HMON) with Controlled Release of Pirfenidone and Ultrasound-Target-Microbubble-Destruction (UTMD) for Pancreatic Cancer Treatment
por: Gao, Feng, et al.
Publicado: (2019) -
Photo-responsive degradable hollow mesoporous organosilica nanoplatforms for drug delivery
por: Fan, Jie, et al.
Publicado: (2020) -
Periodic Mesoporous Organosilica Nanorice
por: Mohanty, Paritosh, et al.
Publicado: (2008) -
Enhanced anti-glioma efficacy of biodegradable periodic mesoporous organosilica nanoparticles through target delivery of chemotherapeutics
por: Dong, Min, et al.
Publicado: (2023)